Francesca Toia Selected Research

Neoplasms (Cancer)

2/2024	Tumor-infiltrating γδ T cells as targets of immune checkpoint blockade in melanoma.
1/2023	Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay.
1/2018	Conservative Surgical Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw with Er,Cr:YSGG Laser and Platelet-Rich Plasma: A Longitudinal Study.
1/2017	Squamous Cell Tumors Recruit γδ T Cells Producing either IL17 or IFNγ Depending on the Tumor Stage.
1/2016	Skewed Differentiation of Circulating Vγ9Vδ2 T Lymphocytes in Melanoma and Impact on Clinical Outcome.
1/2015	Prognostic and predictive biomarkers for targeted therapy in NSCLC: for whom the bell tolls?
5/2014	Prophylactic chimera anterolateral thigh/vastus lateralis flap: preventing complications in high-risk head and neck reconstruction.
1/2012	Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesca Toia Research Topics

Disease

8	Neoplasms (Cancer) 02/2024 - 01/2012
5	Melanoma (Melanoma, Malignant) 02/2024 - 01/2012
5	Infections 01/2024 - 12/2010
2	Fistula 03/2015 - 05/2014
2	Wounds and Injuries (Trauma) 05/2014 - 12/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2023
1	Hypertrophy 01/2023
1	Inflammation (Inflammations) 01/2023
1	Obesity 01/2023
1	Merkel Cell Carcinoma 01/2023
1	Overweight 01/2023
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2022
1	Cicatrix (Scar) 08/2020
1	Neoplasm Metastasis (Metastasis) 10/2019
1	Bisphosphonate-Associated Osteonecrosis of the Jaw 01/2018
1	Male Breast Neoplasms (Male Breast Cancer) 01/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 05/2014
1	Incisional Hernia 05/2012
1	Surgical Wound Infection 05/2012

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2015
3	CytokinesIBA 01/2017 - 01/2012
2	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2023
2	Zoledronic Acid (Zometa)FDA Link 10/2019 - 01/2012
2	SolutionsIBA 03/2015 - 12/2010
1	Programmed Cell Death 1 ReceptorIBA 01/2023
1	LigandsIBA 01/2023
1	ButyrophilinsIBA 01/2023
1	avelumabIBA 01/2023
1	pembrolizumabIBA 01/2023
1	NivolumabIBA 01/2023
1	Gemcitabine FDA Link 01/2022
1	Diphosphonates (Bisphosphonates)IBA 10/2019
1	ChemokinesIBA 01/2017
1	Acetylcysteine (Siran)FDA LinkGeneric 03/2015
1	Saline SolutionIBA 03/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2012
1	AntigensIBA 01/2012
1	boric acid (boron oxide hydroxide)IBA 12/2010
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 12/2010

Therapy/Procedure

3	Immunotherapy 02/2024 - 01/2017
2	Therapeutics 02/2024 - 01/2015
1	General Anesthesia 01/2024
1	Reoperation 04/2023
1	Mammaplasty (Breast Reconstruction) 01/2023
1	Free Tissue Flaps 08/2020
1	Solid-State Lasers 01/2018
1	Modified Radical Mastectomy (Mastectomy, Modified) 01/2017
1	Radiotherapy 03/2015
1	Neck Dissection (Radical Neck Dissection) 05/2014
1	Operative Surgical Procedures 05/2014
1	Antibiotic Prophylaxis 05/2012
1	Debridement 12/2010